Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Uncovering Cryptic Glycan Markers in Multiple Sclerosis (MS) and Experimental Autoimmune Encephalomyelitis (EAE).
[Unified assessment of adverse events of multiple sclerosis disease modifying drugs.]
Vitamin D supplementation and monitoring in multiple sclerosis: who, when and wherefore.
Effects of the Anti-Multiple Sclerosis Immunomodulator Laquinimod on Anxiety and Depression in Rodent Behavioral Models.
Recurrent disease-activity rebound in a patient with multiple sclerosis after natalizumab discontinuations for pregnancy planning.
A possible case of natalizumab-dependent suicide attempt: A brief review about drugs and suicide.
Monitoring the John Cunningham virus throughout natalizumab treatment in multiple sclerosis patients.
Natalizumab treatment reduces endothelial activity in MS patients.
Inhibition of autoimmune encephalomyelitis by a tetracycline.
Progressive multifocal leukoencephalopathy after natalizumab discontinuation.
About Tysabri
The Transcription Factor IRF8 Activates Integrin-Mediated TGF-β Signaling and Promotes Neuroinflammation.
Multiple sclerosis.
Multiple sclerosis and pain.
Re-evaluation of the risk for major adverse cardiovascular events in patients treated with anti-IL-12/23 biological agents for chronic plaque psoriasis: a meta-analysis of randomized controlled trials.
Percutaneous transluminal angioplasty for chronic cerebrospinal venous insufficiency in multiple sclerosis: dichotomy between subjective and objective outcome scores.
Pathophysiology of the brain extracellular matrix: a new target for remyelination.
The path to self-management: a qualitative study involving older people with multiple sclerosis.
Blockade of CD47 ameliorates autoimmune inflammation in CNS by suppressing IL-1-triggered infiltration of pathogenic Th17 cells.
Natalizumab to fingolimod washout in patients at risk of PML: When good intentions yield bad outcomes.
Estimating the proportion of variation in susceptibility to multiple sclerosis captured by common SNPs.
Pregnancy in multiple sclerosis: a questionnaire study.
Documenting outdoor activity and travel behaviour in persons with neurological conditions using travel diaries and GPS tracking technology: a pilot study in multiple sclerosis.
Dilantin (phenytoin) Supplemental Approval Letter
Prognostic indicators for long-term disability in multiple sclerosis patients.
Pages
« first
‹ previous
…
158
159
160
161
162
163
164
165
166
…
next ›
last »